Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Leads, implantable devices
Implantable cardioverter defibrillators (ICD)
Cardiac resynchronization therapy devices (CRT)
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Clinical decision support
7351 Kirkwood Lane North
Maple Grove, MN 55369
April 02, 2015
Drug-coated Balloons Enter the U.S. Market — ACC 2015
The FDA recently approved the first two drug-coated balloons for the U.S.
May 23, 2014
First Drug-Eluting Balloon to Go Before FDA Review Panel in June
May 23, 2014 — The first drug-eluting balloon to go up for review by the U.S. Food and Drug Administration (FDA) will...
January 25, 2012
UH Case Medical Center Among First to Enroll for Drug-Eluting Balloon Trial
January 25, 2012 — Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in LEVANT 2...
January 06, 2012
Bard Acquires Drug-Eluting Balloon Maker Lutonix
January 6, 2012 - C. R. Bard recently announced it acquired drug-eluting balloon maker Lutonix Inc. for $225 million....
July 26, 2011
First Patient Enrolled in Lutonix U.S. Drug-Coated Balloon Pivotal Trial
July 26, 2011 – The first patient has been enrolled in the LEVANT 2 clinical trial, a global, multi-center, randomized...
Scranton Gillette Communications
. All Rights Reserved.